LymphedemaV1, PubMed, Checkpoint, bibRecord, 000742

OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.

Identifieur interne : 000742 ( PubMed/Checkpoint ); précédent : 000741; suivant : 000743

OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.

Auteurs : J. Zhang [Royaume-Uni] ; E. Moore [Royaume-Uni] ; R. Bousfield [Royaume-Uni]

Source :

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [ 1435-4373 ] ; 2016.

RBID : pubmed:27084095

Descripteurs français

KwdFr :
- Adolescent, Adulte, Adulte d'âge moyen, Antibactériens (administration et posologie), Cellulite sous-cutanée (microbiologie), Cellulite sous-cutanée (traitement médicamenteux), Facteurs de risque, Femelle, Humains, Jeune adulte, Mâle, Perfusions parentérales, Résultat thérapeutique, Soins ambulatoires, Sujet âgé, Sujet âgé de 80 ans ou plus, Études rétrospectives.
MESH :
- administration et posologie : Antibactériens.
- microbiologie : Cellulite sous-cutanée.
- traitement médicamenteux : Cellulite sous-cutanée.
- Adolescent, Adulte, Adulte d'âge moyen, Facteurs de risque, Femelle, Humains, Jeune adulte, Mâle, Perfusions parentérales, Résultat thérapeutique, Soins ambulatoires, Sujet âgé, Sujet âgé de 80 ans ou plus, Études rétrospectives.

English descriptors

KwdEn :
- Adolescent, Adult, Aged, Aged, 80 and over, Ambulatory Care, Anti-Bacterial Agents (administration & dosage), Cellulitis (drug therapy), Cellulitis (microbiology), Female, Humans, Infusions, Parenteral, Male, Middle Aged, Retrospective Studies, Risk Factors, Treatment Outcome, Young Adult.
MESH :
- chemical , administration & dosage : Anti-Bacterial Agents.
- drug therapy : Cellulitis.
- microbiology : Cellulitis.
- Adolescent, Adult, Aged, Aged, 80 and over, Ambulatory Care, Female, Humans, Infusions, Parenteral, Male, Middle Aged, Retrospective Studies, Risk Factors, Treatment Outcome, Young Adult.

Abstract

This retrospective study investigated the demographics and treatment outcomes of patients with cellulitis receiving outpatient parenteral antibiotic therapy (OPAT) between 2010 and 2014 in Cambridge University Hospitals. The rate of treatment failure (as indicated by the readmission to hospital) was low, at 5.5%. Risk factors associated with a longer duration of OPAT treatment included: immunosuppression, peripheral vascular disease, obesity, lymphoedema, previous cellulitis and diabetes.

DOI: 10.1007/s10096-016-2631-y
PubMed: 27084095

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 000873
to stream PubMed, to step Curation: 000873

Links to Exploration step

pubmed:27084095

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.</title>
<author><name sortKey="Zhang, J" sort="Zhang, J" uniqKey="Zhang J" first="J" last="Zhang">J. Zhang</name>
<affiliation wicri:level="4"><nlm:affiliation>School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0SP, UK. jz325@cam.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0SP</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName><settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Moore, E" sort="Moore, E" uniqKey="Moore E" first="E" last="Moore">E. Moore</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ</wicri:regionArea>
<wicri:noRegion>CB2 0QQ</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bousfield, R" sort="Bousfield, R" uniqKey="Bousfield R" first="R" last="Bousfield">R. Bousfield</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ</wicri:regionArea>
<wicri:noRegion>CB2 0QQ</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27084095</idno>
<idno type="pmid">27084095</idno>
<idno type="doi">10.1007/s10096-016-2631-y</idno>
<idno type="wicri:Area/PubMed/Corpus">000873</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000873</idno>
<idno type="wicri:Area/PubMed/Curation">000873</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000873</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000873</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000873</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.</title>
<author><name sortKey="Zhang, J" sort="Zhang, J" uniqKey="Zhang J" first="J" last="Zhang">J. Zhang</name>
<affiliation wicri:level="4"><nlm:affiliation>School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0SP, UK. jz325@cam.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0SP</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName><settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Moore, E" sort="Moore, E" uniqKey="Moore E" first="E" last="Moore">E. Moore</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ</wicri:regionArea>
<wicri:noRegion>CB2 0QQ</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bousfield, R" sort="Bousfield, R" uniqKey="Bousfield R" first="R" last="Bousfield">R. Bousfield</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ</wicri:regionArea>
<wicri:noRegion>CB2 0QQ</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology</title>
<idno type="eISSN">1435-4373</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Ambulatory Care</term>
<term>Anti-Bacterial Agents (administration & dosage)</term>
<term>Cellulitis (drug therapy)</term>
<term>Cellulitis (microbiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Infusions, Parenteral</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Antibactériens (administration et posologie)</term>
<term>Cellulite sous-cutanée (microbiologie)</term>
<term>Cellulite sous-cutanée (traitement médicamenteux)</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Perfusions parentérales</term>
<term>Résultat thérapeutique</term>
<term>Soins ambulatoires</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Anti-Bacterial Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antibactériens</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Cellulitis</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Cellulite sous-cutanée</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Cellulitis</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Cellulite sous-cutanée</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Ambulatory Care</term>
<term>Female</term>
<term>Humans</term>
<term>Infusions, Parenteral</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Risk Factors</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Facteurs de risque</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Perfusions parentérales</term>
<term>Résultat thérapeutique</term>
<term>Soins ambulatoires</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">This retrospective study investigated the demographics and treatment outcomes of patients with cellulitis receiving outpatient parenteral antibiotic therapy (OPAT) between 2010 and 2014 in Cambridge University Hospitals. The rate of treatment failure (as indicated by the readmission to hospital) was low, at 5.5%. Risk factors associated with a longer duration of OPAT treatment included: immunosuppression, peripheral vascular disease, obesity, lymphoedema, previous cellulitis and diabetes.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27084095</PMID>
<DateCreated><Year>2016</Year>
<Month>05</Month>
<Day>30</Day>
</DateCreated>
<DateCompleted><Year>2017</Year>
<Month>02</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1435-4373</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>35</Volume>
<Issue>6</Issue>
<PubDate><Year>2016</Year>
<Month>Jun</Month>
</PubDate>
</JournalIssue>
<Title>European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology</Title>
<ISOAbbreviation>Eur. J. Clin. Microbiol. Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.</ArticleTitle>
<Pagination><MedlinePgn>1013-5</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s10096-016-2631-y</ELocationID>
<Abstract><AbstractText>This retrospective study investigated the demographics and treatment outcomes of patients with cellulitis receiving outpatient parenteral antibiotic therapy (OPAT) between 2010 and 2014 in Cambridge University Hospitals. The rate of treatment failure (as indicated by the readmission to hospital) was low, at 5.5%. Risk factors associated with a longer duration of OPAT treatment included: immunosuppression, peripheral vascular disease, obesity, lymphoedema, previous cellulitis and diabetes.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName>
<ForeName>J</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0SP, UK. jz325@cam.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Moore</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bousfield</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Department of Infectious Diseases, Addenbrooke's Hospital, Cambridge, CB2 0QQ, UK.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>04</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Eur J Clin Microbiol Infect Dis</MedlineTA>
<NlmUniqueID>8804297</NlmUniqueID>
<ISSNLinking>0934-9723</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000553" MajorTopicYN="Y">Ambulatory Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002481" MajorTopicYN="N">Cellulitis</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007263" MajorTopicYN="Y">Infusions, Parenteral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year>
<Month>03</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>03</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>2</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27084095</ArticleId>
<ArticleId IdType="doi">10.1007/s10096-016-2631-y</ArticleId>
<ArticleId IdType="pii">10.1007/s10096-016-2631-y</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Angleterre de l'Est</li>
</region>
<settlement><li>Cambridge</li>
</settlement>
<orgName><li>Université de Cambridge</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Zhang, J" sort="Zhang, J" uniqKey="Zhang J" first="J" last="Zhang">J. Zhang</name>
</region>
<name sortKey="Bousfield, R" sort="Bousfield, R" uniqKey="Bousfield R" first="R" last="Bousfield">R. Bousfield</name>
<name sortKey="Moore, E" sort="Moore, E" uniqKey="Moore E" first="E" last="Moore">E. Moore</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000742 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000742 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:27084095
   |texte=   OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:27084095" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.

OPAT for cellulitis: its benefits and the factors that predispose to longer treatment.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki